Updated from 6 a.m. EDT
Here are 10 things you should know for Monday, March 14:
1. -- U.S. stock futures slipped Monday but European and Asian shares rose ahead of meetings this week of global central bankers.
The Bank of Japan meets Tuesday, the Federal Reserve will issue a decision on interest rates on Wednesday and the Bank of England meets on Thursday.
Expectations are that U.S. officials won't raise rates at the March meeting but could do so in June following some encouraging data on the U.S. economy. Last week, the European Central Bank promised further stimulus to boost the eurozone economy.
2. -- The economic calendar in the U.S. Monday is bare.
3. -- U.S. stocks on Friday ended higher, rising on the back of another surge in crude oil.
Stocks closed out their fourth straight week of gains. The S&P 500 rose 1.6% on Friday, trading above 2,000 again. The Dow Jones Industrial Average added 1.3%, and the Nasdaq was up 1.9%, pulling out of correction territory.
West Texas Intermediate crude oil closed Friday with a gain of 1.7%, its best settlement since December. Early Monday, crude oil fell 2% to $37.71 a barrel.
The stock soared 9.3% to $77 in premarket trading on Monday.
The agreement with China's Anbang Insurance Group comes about three months since the private-equity firm completed its acquisition of the luxury hotel operator.
The person couldn't immediately say how much of the $6.5 billion deal value includes debt.
Blackstone completed its acquisition of Strategic Hotels in December. That deal was valued at $3.93 billion, or about $6 billion, including debt.
The companies confirmed the agreement in a press release Monday.
Apollo prevailed in an auction for Fresh Market with a cash offer of $28.50 a share, Reuters reported.
Fresh Market shares closed Friday at $22.98.
The Manhattan federal court trial that begins on Monday is meant to define legal boundaries that may aid the settlement of hundreds of lawsuits filed after GM revealed that it had continued to sell flawed cars after discovering an ignition switch defect in Chevy Cobalts and other small cars, the Associated Press reported. Since early 2014, GM has issued recalls affecting more than 30 million vehicles.
The trial comes after the jury in an earlier trial was dismissed after both sides dropped the case when questions arose about the plaintiff's truthfulness. The trials are among six scheduled for this year, according to the AP.
Pfizer's India unit told Reuters it had stopped selling its Corex cough syrup that contains codeine, a narcotic. Abbott, which sells the syrup under the Phensedyl brand name, didn't respond to a request for comment.
The medicines, which are a combination of chlopheniramine maleate and codeine, were among 344 drug combinations India banned over the weekend after a government panel of experts found they had "no therapeutic justification," Reuters reported.
Shares of the India-based units of both companies fell as much as 5% on Monday.
9. -- The top two executives at Chipotle Mexican Grill (CMG - Get Report) suffered big pay cuts after a series of food scares sent sales plunging toward the end of 2015.
Steve Ells was given a pay package worth $13.8 million for last year, down from $28.9 million the previous year. Monty Moran was given compensation worth $13.6 million, down from $28.2 million. The packages include a salary, stock awards and other perks.
Chipotle also said that because it ended the year with a damaged stock price, it adjusted the vesting of the executive's stock awards for 2016 to ensure shareholder's value is first met. As a result, the awards will pay out only if the average 30-day closing price of Chipotle's common stock at any point during the fiscal year is at least $700, which is about 52% higher than the closing price on the grant date.
Chipotle shares closed Friday at $507.85.